tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX

Vertex Pharmaceuticals (VRTX) Revenue

Compare
6,034 Followers

Vertex Pharmaceuticals Revenue

Vertex Pharmaceuticals had a revenue of 2.91B in the quarter ending Dec 31, 2024, with 5.05%. This bring the company's revenue in the last twelve months to 11.01B, Decreased 3.72%. In the fiscal year ending Dec 31, 2024, Vertex Pharmaceuticals had annual revenue of 11.02B with 11.66% growth.
Revenue (ttm)
11.01B
Revenue Growth
11.64%
P/S Ratio
11.52
Revenue/Employee
$1,806,574
Employees
6,100
Market Cap
$126.96B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202411.02B1.15B+11.66%
Dec 31, 20239.87B938.50M+10.51%
Dec 31, 20228.93B1.36B+17.91%
Dec 31, 20217.57B1.37B+22.06%
Dec 31, 20206.21B2.04B+49.07%
Dec 31, 20194.16B1.12B+36.59%
Dec 31, 20183.05B558.95M+22.46%
Dec 31, 20172.49B786.48M+46.20%
Dec 31, 20161.70B669.84M+64.89%
Dec 31, 20151.03B451.92M+77.86%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis